IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $52,000 | -21.2% | 10,780 | -26.8% | 0.00% | 0.0% |
Q2 2022 | $66,000 | -4.3% | 14,726 | +0.9% | 0.00% | 0.0% |
Q1 2022 | $69,000 | -46.9% | 14,591 | -16.5% | 0.00% | -50.0% |
Q4 2021 | $130,000 | +3.2% | 17,484 | -21.1% | 0.00% | 0.0% |
Q3 2021 | $126,000 | -20.3% | 22,151 | -7.6% | 0.00% | 0.0% |
Q2 2021 | $158,000 | -19.0% | 23,971 | -0.5% | 0.00% | -33.3% |
Q1 2021 | $195,000 | +10.8% | 24,100 | -11.5% | 0.00% | 0.0% |
Q4 2020 | $176,000 | +58.6% | 27,246 | -11.3% | 0.00% | +50.0% |
Q3 2020 | $111,000 | -23.4% | 30,726 | -2.2% | 0.00% | -33.3% |
Q2 2020 | $145,000 | +43.6% | 31,427 | +5.6% | 0.00% | 0.0% |
Q1 2020 | $101,000 | -33.1% | 29,763 | +0.6% | 0.00% | 0.0% |
Q4 2019 | $151,000 | +125.4% | 29,583 | +6.4% | 0.00% | +200.0% |
Q3 2019 | $67,000 | +8.1% | 27,802 | -3.3% | 0.00% | 0.0% |
Q2 2019 | $62,000 | -24.4% | 28,741 | -5.4% | 0.00% | -50.0% |
Q1 2019 | $82,000 | -41.4% | 30,388 | +4.0% | 0.00% | -50.0% |
Q4 2018 | $140,000 | -48.1% | 29,233 | +2.5% | 0.00% | -42.9% |
Q3 2018 | $270,000 | -1.1% | 28,526 | -25.8% | 0.01% | -22.2% |
Q2 2017 | $273,000 | +79.6% | 38,429 | -2.2% | 0.01% | +50.0% |
Q1 2017 | $152,000 | – | 39,301 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |